论文信息 - Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study. - 字舞流文

Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study.

E. Carrasco | L. Calvo | A. Antón | M. Muñoz | S. Antolín | A. Plazaola | A. Ruiz | A. Santaballa | P. Sánchez | J. Lao | J. Alfaro | A. Miguel | J. Camps | M. Seguí | M. Cámara